- Home
- USIO vs IINN Comparison
USIO vs IINN Comparison
Compare USIO & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | USIO | IINN |
|---|---|---|
| Founded | 1998 | 2018 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.0M | 35.3M |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | USIO | IINN |
|---|---|---|
| Price | $1.10 | $0.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $4.00 | $2.00 |
| AVG Volume (30 Days) | 56.7K | ★ 156.2K |
| Earning Date | 03-18-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $28,200,535.00 | N/A |
| Revenue This Year | $15.47 | $16,841.18 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.69 | N/A |
| 52 Week Low | $1.03 | $0.34 |
| 52 Week High | $2.02 | $1.65 |
Technical Indicators
Market Signals| Indicator | USIO | IINN |
|---|---|---|
| Relative Strength Index (RSI) | 34.19 | 20.05 |
| Support Level | $1.03 | N/A |
| Resistance Level | $1.42 | $0.63 |
| Average True Range (ATR) | 0.07 | 0.04 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 31.18 | 19.43 |
Price Performance
Historical ComparisonAbout USIO Usio Inc.
Usio Inc is a United States-based company that provides integrated electronic payment services, including credit and debit card-based processing services and transaction processing via the Automated Clearing House, or ACH network to billers and retailers. The Company also has an additional wholly-owned subsidiary, which is the entity for Output Solutions operations.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.